- Exhibit & Support
- Travel & Hotels
Medication adherence challenges are exacerbated in patients with chronic medical and mental health conditions, with nonadherence reaching as high as 90% in those with schizophrenia. Long-acting injectable antipsychotics have been introduced to contend with poor adherence and improve clinical and economic outcomes. Learn more about them and how to select the right one for your patients with schizophrenia.
At the completion of this application-based activity, participants will be able to: